J Korean Assoc Oral Maxillofac Surg.  2015 Feb;41(1):19-25. 10.5125/jkaoms.2015.41.1.19.

Quality of life following surgical treatment of oral cancers

• Efunkoya A
• Adebola RA
• Omeje KU
• Amole IO
• Akhiwu BI
• Osunde DO

• KMID: 2328649
• DOI: http://doi.org/10.5125/jkaoms.2015.41.1.19

Abstract

INTRODUCTION
Quality of life (QoL) studies provide information about the impact of disease, the treatment of symptoms, and outcomes following treatment. The present study aims to evaluate the postoperative QoL of patients treated for oral cancer in a Nigerian government tertiary hospital.
MATERIALS AND METHODS
A prospective study on consenting patients with oral cancer was undertaken at Aminu Kano Teaching Hospital, Kano, Nigeria. The subjects completed the University of Washington QoL (UW-QoL) questionnaire one day prior to surgery and postoperatively after 7 days, 1 month, 3 months, and 6 months.
RESULTS
Sixty-eight patients with oral cancer were recruited. Of these, 38 were males, and 30 were females (male : female, 1.3 : 1). Twenty-four patients (12 males and 12 females) underwent surgery and completed postoperative QoL assessment using the UW-QoL questionnaire. Preoperative QoL mean score was 2.21, while postoperative mean scores after 1 week, 1 month, 3 months, and 6 months were 3.67, 3.46, 2.82, and 2.61, respectively.
CONCLUSION
An improvement in QoL following surgical treatment for patients with oral cancer was observed. 'Appearance,' 'recreation,' and 'chewing' were identified as the most important determinants of postoperative QoL in patients with oral cancer in our study.

Keyword

Quality of life; Oral cancer; Surgery

MeSH Terms

Female
Hospitals, Teaching
Humans
Male
Mouth Neoplasms*
Nigeria
Prospective Studies
Quality of Life*
Surveys and Questionnaires
Tertiary Care Centers
Washington

Reference

1. Marx RE, Stern D. Oral and maxillofacial pathology: a rationale for diagnosis and treatment. Chicago: Quintessence Publishing;2003. p. 283–293.

2. Tang XH, Knudsen B, Bemis D, Tickoo S, Gudas LJ. Oral cavity and esophageal carcinogenesis modeled in carcinogen-treated mice. Clin Cancer Res. 2004; 10:301–313. PMID: 14734483.

3. Hotary K, Allen E, Punturieri A, Yana I, Weiss SJ. Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3. J Cell Biol. 2000; 149:1309–1323. PMID: 10851027.

4. Kaplan RN, Rafii S, Lyden D. Preparing the "soil": the premetastatic niche. Cancer Res. 2006; 66:11089–11093. PMID: 17145848.

5. Carnelio S, Rodrigues G. Oral cancer at a glance. Internet J Dent Sci [Internet]. 2003; 1(2):cited 2013 Mar 21. Available from: https://ispub.com/IJDS/1/2/5720.

6. SEER cancer statistics review, 1975-2005 [Internet]. Bethesda(MD): National Cancer Institute;cited 2009 Jan 26. Available from: http://seer.cancer.gov/archive/csr/1975_2005.

7. World Health Organization (WHO). International statistical classification of diseases and related health problems. 10th revision. Geneva: WHO;1992. p. 42–57.

8. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer. 1993; 54:594–606. PMID: 8514451.

9. The Oral Cancer Foundation [Internet]. Newport Beach (CA): The Oral Cancer Foundation;cited 2006 May 28. Available from: http://www.oralcancerfoundation.org.

10. Levi F, Lucchini F, La Vecchia C. Worldwide patterns of cancer mortality, 1985-89. Eur J Cancer Prev. 1994; 3:109–143. PMID: 7517250.

11. Rogers SN, Laher SH, Overend L, Lowe D. Importance-rating using the University of Washington quality of life questionnaire in patients treated by primary surgery for oral and oro-pharyngeal cancer. J Craniomaxillofac Surg. 2002; 30:125–132. PMID: 12069517.

12. Goldspiel BR, Green L, Calis KA. Human gene therapy. Clin Pharm. 1993; 12:488–505. PMID: 8354036.

13. Arotiba GT, Ladeinde AL, Oyeneyin JO, Nwawolo CC, Banjo AA, Ajayi OF. Malignant orofacial neoplasms in Lagos, Nigeria. East Afr Med J. 2006; 83:62–68. PMID: 16771101.

14. Ajayi OF, Adeyemo WL, Ladeinde AL, Ogunlewe MO, Effiom OA, Omitola OG, et al. Primary malignant neoplasms of orofacial origin: a retrospective review of 256 cases in a Nigerian tertiary hospital. Int J Oral Maxillofac Surg. 2007; 36:403–408. PMID: 17391919.

15. Adekeye EO, Asamoa E, Cohen B. Intraoral carcinoma in Nigeria: a review of 137 cases. Ann R Coll Surg Engl. 1985; 67:180–182. PMID: 4004050.

16. Ugboko V, Ajike S, Olasoji H, Pindiga H, Adebiyi E, Omoniyi-Esan G, et al. Primary orofacial squamous cell carcinoma: a multicenter Nigerian study. Internet J Dent Sci [Internet]. 2003; 1(2):cited 2013 May 5. Available from: https://ispub.com/IJDS/1/2/10778.

17. Arotiba JT, Obiechina AE, Fasola OA, Fawole OI, Ajagbe HA. Oral squamous cell carcinoma: a review of 246 Nigerian cases. Afr J Med Med Sci. 1999; 28:141–144. PMID: 11205818.

18. Lippman SM, Sudbø J, Hong WK. Oral cancer prevention and the evolution of molecular-targeted drug development. J Clin Oncol. 2005; 23:346–356. PMID: 15637397.

19. Kanatas AN, Rogers SN. A national survey of health-related quality of life questionnaires in head and neck oncology. Ann R Coll Surg Engl. 2004; 86:6–10. PMID: 15005937.

20. Rogers SN, Ahad SA, Murphy AP. A structured review and theme analysis of papers published on 'quality of life' in head and neck cancer: 2000-2005. Oral Oncol. 2007; 43:843–868. PMID: 17600755.

21. Atchison KA, Shetty V, Belin TR, Der-Martirosian C, Leathers R, Black E, et al. Using patient self-report data to evaluate orofacial surgical outcomes. Community Dent Oral Epidemiol. 2006; 34:93–102. PMID: 16515673.